Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 4, 2003 - Issue 8
Submit an article Journal homepage
35
Views
4
CrossRef citations to date
0
Altmetric
Review

Treatment options of AIDS-related lymphoma

Ingo GH Schmidt-Wolf Medizinische Klinik und Poliklinik I, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany. [email protected]
,
Jürgen K Rockstroh Medizinische Klinik und Poliklinik I, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany. [email protected]
,
Uwe Schlegel Medizinische Klinik und Poliklinik I, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany. [email protected]
,
Hendrik Pels Medizinische Klinik und Poliklinik I, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany. [email protected]
,
Ulrich Mey Medizinische Klinik und Poliklinik I, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany. [email protected]
,
John Strehl Medizinische Klinik und Poliklinik I, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany. [email protected]
,
Rudolf Weiss Medizinische Klinik und Poliklinik I, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany. [email protected]
&
Dieter Huhn Medizinische Klinik und Poliklinik I, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany. [email protected]
 show all
Pages 1331-1343 | Published online: 02 Mar 2005

Bibliography

  • AMMASSARI A, CINGOLANI A, PEZZOTTI P et al.: AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology (2000) 55:1194–1200.
  • ANTINORI A, CINGOLANI A, ALBA L et al.: Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS (2001) 15:1483–1491.
  • ANTINORI A, DE ROSSI G, AMMASSARI A et al: Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma. Clin. Oncol. (1999) 17:554–560.
  • BAIOCCHI OC, COLLEONI GW, NAVAJAS EV et al: Impact of highly active antiretroviral therapy in the treatment of HIV-infected patients with systemic non-Hodgkin's lymphoma. Acta Oncol. (2002) 41(2):192–196.
  • BESSON C, GOUBAR A, GABARRE J et al: Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood (2001) 96(8):2339–2344.
  • •This is an important paper on the impact of HAART with AIDS-related non-Hodgkin's lymphoma.
  • CHAMBERLAIN MC: Long survival in patients with AIDS-related primary CNS lymphoma. Cancer (1994) 73:1728–1730.
  • COIFFIER B, HAIOUN C, KETTERER N et al.: Ritwdmab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter Phase II study. Blood (1998) 92(6):1927–1932.
  • COIFFIERB, LEPAGE E, BRIERE Jet al: CHOP chemotherapy plus ritwdmab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl. I Med. (2002) 346(4):235–242.
  • ••This is a landmark paper on the use of rituzintab in combination with CHOP for patients with non-Hodgkin's lymphoma.
  • CONTU L, LA NASA G, ARRAS M et al: Allogeneic bone marrow transplantation combined with multiple anti-HIV-1 treatment in a case of AIDS. Bone Marrow Transplant. (1993) 12:669–671.
  • DAL MASO L, FRANCESCHI S: Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol. (2003) 4:110–119.
  • DONAHUE BR, SULLIVAN JW, COOPER JS: Additional experience with empiric radiotherapy for presumed human immunodeficiency virus-associated primary central nervous system lymphoma. Cancer (1995) 76:328–332.
  • FISHER RI, GAYNOR ER, DAHLBERG S et al: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin lymphoma. N Engl. Med. (1993) 328(14):1002–1006.
  • •This is an important paper on the role of CHOP as compared to other treatments in patients with non-Hodgkin's lymphoma.
  • FORSYTH PA, YAHOLOM J, DE ANGELIS LM: Combined modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology (1994) 44:1473–1478.
  • GASTALDI R, MARTINO P, GENTILE G et al: High dose of idarubicin-based regimen for diffuse large cell AIDS-related NHL patients: a pilot study. Haematologica (2001) 86(10):1051–1059.
  • GERARD L, GALICIER L, MALLARD A et al.: Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV-replication: persistent occurrence but improved survival.' Acquit: knmuneDel Syndr. (2002) 30:478–484.
  • GILL PS, LEVINE AM, KRAILO Metal: AIDS-related malignant lymphoma: results of prospective treatment trials. Clin. Oncol. (1987) 5:1322–1328.
  • GISSELBRECHT C, OKSENJENDLER E, TIRELLI U et al.: Non-Hodgkin lymphoma associated with human immunodeficiency virus: Treatment with LNH 84 regimen in a selected group of patients. Leukemia (1992) 6(3):10–11.
  • Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus infected adults. International Collaboration of HIV and Cancer. Natl. Cancer Inst. (2000) 92:1823–1830.
  • HOFFMANN C, TABRIZIAN S, WOLF E et al: Survival of AIDS-patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS (2002) 16:1195–1196.
  • •This is an important paper on the effect of HAART on PCNSL in AIDS-related patients.
  • HOFFMANN C, TAPRIZIAN S, WOLF E et al.: Survival of AIDS patients with primary central nervous system lymphoma (PCNSL) is dramatically improved by HAART-induced immune recovery. AIDS (2001) 15(16):2119–2127.
  • HSU FJ, CASPAR CB, CZERWINSKI D et al.: Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma-long-term results of a clinical trial. Blood(1997) 89(9):3129–3135.
  • HUHN D: HIV-assozfierte Lymphome. In: Internistische Onkologie, (2'd edn)Wilmanns W, Huhn D, Wilms K (Eds), Stuttgart, Thieme (2000):429.
  • HUZICKA I: Could bone marrow transplantation cure AIDS?: review. Med. Hypotheses (1999) 52(3):247–257.
  • INUNGU J, MELENDEZ ME MONTGOMERY JP: AIDS-related primary brain lymphoma in Michigan, January 1990 to December 2000. AIDS Patient Care STDS (2002) 16:107–112.
  • IVES NJ, GAZZARD BE, EASTERBROOK PJ: The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic. Infect. (2001) 42:134–139.
  • KANG EM, DE WITTE M, MALECH H et al.: Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome. Blood (2002) 99(2):698–701.
  • KAPLAN LD, STRAUS DJ, TESTA MA et al.: Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl. Med. (1997) 336:1641–1648.
  • •An important paper on BACOD treatment of patients with AIDS-related non-Hodgkin's lymphoma.
  • KERSTEN MJ, KLEIN MR, HOLWERDA AM et al: Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin lymphoma. Clin. Invest. (1997) 99:1525–1533.
  • KIRK 0, PEDERSEN C, COZZI-LEPRI A et al.: Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood (2001) 98(12):3406–3412.
  • LEVINE AM: Acquired immunodeficiency syndrome-related lymphoma: clinical aspects. Semin. Oncol. (2000) 27:442–453.
  • LEVINE AM, SENEVIRATNE L, ESPINA BM et al: Evolving characteristics of AIDS-related lymphoma. Blood (2000) 96:4084–4090.
  • LEVINE AM, SENEVIRATNE L, TULPULE A: Incidence and management of AIDS-related lymphoma. Oncology (Huntingt) (2001) 15(5):629–639.
  • LEVINE AM, WERNZ JC, KAPLAN L et al: Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial. JAMA (1991) 266:84–88.
  • LITTLE RF, PITTALUGA S, GRANT N et al: Highly effective treatment of AIDS related lymphoma with dose-adjusted EPOCH: Impact of antiretroviral therapy suspension and tumor biology. Blood (2003) 101(12):4653–4659.
  • •Excellent results, in particular, in low risk patients with AIDS-related non-Hodgkin's lymphoma.
  • LITTLE RF, PEARSON D, FRANCHINI G: Dose adjusted EPOCH chemotherapy in previously untreated HIV-associated non-Hodgkin lymphoma: preliminary report to efficacy, immune reconstitution, and HIV control following therapy. Third National AIDS Malignancy Conference, Bethesda, MD. I AIDS (1999) 21:A33 (Abstract 93).
  • LORI F, MALYHK A, CARA A et al.: Hydroxyurea as an inhibitor of Human Immunodeficiency Virus-Type 1 replication. Science (1994) 266:801–805.
  • MITROU PS, SERKE M, POHL C et al: Malignes Lymphom assoziiert mit HIV Infektion. Deutsche Medizinische Wochenschr (1991) 116:1217–1223.
  • MOLINA A, KRISHNAN AY, NADEMANEE A et al.: High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy. Cancer (2000) 89(3):680–689.
  • MURDACA G, CAMPEELLI A, SETTI M et al: Complete remission of AIDS/Kaposi's sarcoma after treatment with a combination of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor. AIDS (2002) 16:304–305.
  • O'DONNELL RT, LEIGH BR, CHRISTENSEN SD et al: Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associated lymphoma. Cancer Biother: Radiopharm. (1999) 14:167–176.
  • OERTEL SH, RUHNKE MS, ANAGNOSTOPOULOS I et al.: Treatment of Epstein-Barr virus-induced post-transplantation lymphoproliferative disorder with foscarnet alone in an adult after simultaneous heart and renal transplantation. Transplantation (1999) 67(5):765–767.
  • OTIENO MW, BANURA C, KATONGOLE-MBIDDE E et al: Therapeutic challenges of AIDS-related non-Hodgkin lymphoma in the United States and East Africa. Natl. Cancer Inst. (2002) May 15;94(10):718–732.
  • PALELLA FJ Jr, DELANEY KM, MOORMAN AC et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl.' Med. (1998) 338:853–860.
  • PORCU P, CALIGIURI MA: Acquired immunodeficiency syndrome-related lymphomas: future directions. Semin. Oncol. (2000) 27:454–462.
  • •This is a good overview.
  • RAEZ LE, PATEL P, FEUN L et al.: Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL). Grit. Rev Oncog. (1998) 9:199–208.
  • RAMQVIST T, MAGNUSSON KP, WANG Y, SZEKELY L, KLEIN G, WIMAN KG: Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53. Oncogene (1993) 8(6):1495–1500.
  • RATNER L, LEE J, TANG S et al.: The AIDS Malignancy Consortium: chemotherapy for human immunodeficiency virus associated non-Hodgkin lymphoma in combination with highly active antiretroviral therapy. Clin. Oncol. (2001) 19:2171–2178.
  • REMICK SC, MCSHARRY JJ, WOLF BC et al.: Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin's lymphoma. Clin. Oncol. (1993) 11:1691–1702.
  • REMICK SC, SEDRANSK N, HAASE RF et al.: Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin lymphoma: evaluation of the role of G-CSF; quality-of-life analysis and long-term follow-up. kn. Hematol. (2001) 66(3):178–188.
  • •This is an interesting paper on oral treatment of AIDS-related non-Hodgkin's lymphoma.
  • SACKTOR N, LYLES RH, SKOLASKY R et al.: HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study; 1990-1998. Neurology (2001) 56:257–260.
  • SCHLEGEL U, SCHMIDT-WOLF IGH, DECKERT M: Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment. J. Neurol Sci. (2000) 181:1–12.
  • SCHMIDT-WOLF IGH, ROCKSTROH JK, SCHLEGEL U et al.: New aspects in the treatment of AIDS-related lymphoma. Eur: j Med. Res. (2002) 7(7):295–303.
  • SCHNEIDER U, RUHNKE M, DELECLUSE HJ et al.: Regression of Epstein-Barr virus-associated lymphoproliferative disorders in patients with aquired immunodeficiency syndrome during therapy with foscarnet.Ann. Hematol. (2000) 79:214–216.
  • •An interesting novel approach using foscarnet in patients with EBV-associated lymphoproliferative disease.
  • SCHNEIDER U, RUHNKE M, DELECLUSE HJ et al: Treatment of EBV-associated lymphoproliferative disorders in HIV-infected patients with foscarnet. Acquit: Immune Defic. Syndr. Hum. Retrovirol. (1997) 14: 97.
  • SLOBOD KS, TAYLOR GH, SANDLUND JT et al.: Epstein-Barr virus-targeted therapy for AIDS-related primary lymphoma of the central nervous system. Lancet (2000) Oct 28;356(9240):1493–1494.
  • SMALLEY RV, ANDERSEN JW, HAWKINS MJ et al.: Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin lymphoma. N Engl. I Med. (1992) 327(19):1336–1341.
  • SPARANO JA, WIERNIK PH, HU X et al.: Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin lymphoma. Oncol. (1996) 14:3026–3035.
  • SPARANO JA, WIERNIK PH, STRACK M et al.: Infusional cyclophosphamide, doxorubicin and etoposide in HIV-Related non-Hodgkin lymphoma: a follow-up report of a highly active regimen. Leak. Lymphoma (1994) 14:263–271.
  • SPINA M, GABARRE J, ROSSI G et al:Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. Blood (2002) 100(6):1984–1988.
  • •Excellent results in patients with Hodgkin's disease and AIDS.
  • SPINA M, SPARANO JA, JAEGER U et al.: Ritwdmab and chemotherapy is highly effective in patients with CD20-positive non-Hodgkin lymphoma and HIV infection. AIDS (2003) 17(0:137–138.
  • •An important novel treatment approach of rituxirnab plus chemotherapy in patients with AIDS-related non-Hodgkin's lymphoma.
  • TIRELLI U, ERRANTE D, DOLCETTI R et al.: Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.Oncol. (1995) 13(7):1758–1767.
  • •This is an important paper on Hodgkin's disease in patients with AIDS.
  • TIRELLI U, ERRANTE D, SPINA M et al.: Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients. Cancer (1996) 77:2127–2131.
  • TIRELLI U, SPINA M, JAEGER U et al.:Infusional CDE with rituximab for the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: preliminary results of a Phase I/II study. Recent Results Cancer Res. (2002) 159:149–153.
  • TOSSING G: New developments in interferon therapy. Eur: Med. Res. (2001) 6(2):47–65.
  • TULPULE A, LEVINE A: AIDS-related lymphoma. Blood Rev (1999) 13:147–150.
  • TURTURRO F, HEINEKE HL, DREVYANKO TF et al: Adenovirus-p53-mediated gene therapy of anaplastic large cell lymphoma with t(2,5) in a nude mouse model. Gene Then (2000) 7(11):930–933.
  • TURTURRO F, SETH P, LINK CJ Jr: In vitro adenoviral vector p53-mediated transduction and killing correlates with expression of coxsackie-adenovirus receptor and alpha(nu)beta5 integrin in SUDHL-1 cells derived from anaplastic large-cell lymphoma. Clin. Cancer Res. (2000) 6(1):185–192.
  • VACCHER E, SPINA M, DI GENNARO G et al: Concomitant cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus related non-Hodgkin lymphoma. Cancer (2001) 91:155–163.
  • •This is an interesting comparative study on the effect of HAART in AIDS-related non-Hodgkin's lymphoma patients.
  • WEISS R: Behandlung HIV-assoziierter Lymphome. Vorteil durch IFN-alpha? Ecomed-Verlagsgesellschaft AG & Co. KG, Landsberg, Germany (1999):124–127.
  • WEISS R, GOLKEL L, ARASTEH K et al: HIV-related lymphoma: Rituximab concomitant to second-line chemotherapy following tumor progression under CHOP or early relapse. Blood (2001) 98(11) (Suppl. 2):253b.
  • WEISS R, HUHN D, MITROU P et al: HIV-related non-Hodgkin's lymphoma: CHOP induction therapy and interferon-alpha-2b/zidovudine maintenance therapy. Leak. Lymphoma (1998) 29:103–118.
  • WEISS R, MITROU P, ARASTEH K et al.: HIV-related lymphoma: changes in immune parameters and viral load during chemotherapy. Blood (2000) 96(11):134a.
  • WIERNIK PH: Treatment of human immunodeficiency virus-related lymphoma. Semin. Hematol. (2001) Oct;38(4 Suppl. 10):27–31.
  • WILDE JT, LEE CA, DARBY SC et al.: UK Haemophilia Center Doctor's Organisation: the incidence of lymphoma in the UK haemophilia population between 1978 and 1999. AIDS (2002) 16: 1803-1807.
  • WUNDERLICH A, KLOESS M, REISER M et al.: Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Ann. Oncol. (2003) 14(6):881–893.

Websites

  • http://clinicaltrials.gov. List of clinical trials of the NCI for patients with lymphoma and AIDS.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.